Welcome To The Mannkind HUB On AGORACOM
Edit this title from the Fast Facts Section
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

Xylitol Canada Discusses 60% Revenue Growth for the 9 Months Ended Sept 30th

Welcome to “Beyond The Press Release” a production of AGORACOM in which we speak with small cap executives about their recent press releases. With us today is Matt Willer, VP of Sales and Marketing of Xylitol Canada.

Xylitol Canada is a fast growing natural sweetener company that manufactures 100% North American derived Xylitol Products. Xylitol recently announced 60% revenue growth for the nine months ended Sept 30, 2014.

Hub On AGORACOM / Corporate Profile / Watch Interview!

Message: Afrezza sales could be higher than Exubera, says Summer Street

Barney-fife-crop-fix
Rank: [?]
President
Points: [?]
5492
Rating: [?]
Votes: 21 Score: 4.5
  • Currently 4.5/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Afrezza sales could be higher than Exubera, says Summer Street

posted on Jul 16, 13 09:52AM

"Summer Street believes that if approved, sales of MannKind's (MNKD) inhalable insulin Afrezza could be "substantially higher" than Pfizer’s (PFE) Exubera given Afrezza’s ease of use. However, the firm adds that it cannot accurately predict future sales of Afrezza at this time."

http://www.theflyonthewall.com/permalinks/entry.php/MNKD;PFEid1858409/MNKD;PFE-Afrezza-sales-could-be-higher-than-Exubera-says-Summer-Street

New Message

Please login to post a reply

AGORACOM Quick Tips

Bullish On China? AGORACOM Launches ChinaSecurities.com ... Check It Out

President's D.D.

Here's the latest Griffin report read more

Stock Quote

Hub Leaders